Special Counsel Andrew Baluch was quoted in an October 31, 2013 Law360 article titled “Expanding Biz Method Review Could Swamp USPTO.” The article discusses how if Congress expands a program that allows greater scrutiny of some business method patents as part of a bill aimed at cracking down on so-called patent trolls, it risks overwhelming the U.S. Patent and Trademark Office and weakening patent rights. Baluch was quoted saying, “I’m very worried about giving the patent office another mandate without being sure it has the resources to handle the extra work.”
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.